{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T04:33:36Z","timestamp":1742358816820,"version":"3.40.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CMRPG6M0401"],"award-info":[{"award-number":["CMRPG6M0401"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPD1M0023","CMRPD1M0013"],"award-info":[{"award-number":["CMRPD1M0023","CMRPD1M0013"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s11096-024-01853-4","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T13:21:18Z","timestamp":1734528078000},"page":"462-470","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prophylaxis of topical levofloxacin against endophthalmitis after cataract surgery in Taiwan, 2001\u20132019: an interrupted time series analysis"],"prefix":"10.1007","volume":"47","author":[{"given":"Jiahn-Shing","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Ru","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Hung","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1379-8969","authenticated-orcid":false,"given":"Lai-Chu","family":"See","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"1853_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.joco.2016.05.002","volume":"28","author":"H Hashemian","year":"2016","unstructured":"Hashemian H, Mirshahi R, Khodaparast M, et al. Post-cataract surgery endophthalmitis: brief literature review. J Curr Ophthalmol. 2016;28:101\u20135.","journal-title":"J Curr Ophthalmol"},{"key":"1853_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ophtha.2015.08.023","volume":"123","author":"M Jabbarvand","year":"2016","unstructured":"Jabbarvand M, Hashemian H, Khodaparast M, et al. Retraction notice to: endophthalmitis occurring after cataract surgery: outcomes of more than 480 000 cataract surgeries, epidemiologic features, and risk factors. Ophthalmology. 2016;123:295\u2013301.","journal-title":"Ophthalmology"},{"key":"1853_CR3","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.jcrs.2011.06.018","volume":"37","author":"M Packer","year":"2011","unstructured":"Packer M, Chang DF, Dewey SH, et al. Prevention, diagnosis, and management of acute postoperative bacterial endophthalmitis. J Cataract Refract Surg. 2011;37:1699\u2013714.","journal-title":"J Cataract Refract Surg"},{"key":"1853_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.18240\/ijo.2022.02.20","volume":"15","author":"SL Shi","year":"2022","unstructured":"Shi SL, Yu XN, Cui YL, et al. Incidence of endophthalmitis after phacoemulsification cataract surgery: a meta-analysis. Int J Ophthalmol. 2022;15:327\u201335.","journal-title":"Int J Ophthalmol"},{"key":"1853_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ophtha.2021.09.004","volume":"129","author":"S Zafar","year":"2022","unstructured":"Zafar S, Dun C, Srikumaran D, et al. Endophthalmitis rates among medicare beneficiaries undergoing cataract surgery between 2011 and 2019. Ophthalmology. 2022;129:250\u20137.","journal-title":"Ophthalmology"},{"key":"1853_CR6","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/ceo.14288","volume":"51","author":"CH Hou","year":"2023","unstructured":"Hou CH, Lee JS, Lin KK, et al. Risk and dose\u2013response relationship of diabetes mellitus for endophthalmitis after cataract surgery in a nationwide cohort study in Taiwan. Clin Exp Ophthalmol. 2023;51:692\u2013703.","journal-title":"Clin Exp Ophthalmol"},{"key":"1853_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0161-6420(01)00899-5","volume":"109","author":"TA Ciulla","year":"2002","unstructured":"Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology. 2002;109:13\u201324.","journal-title":"Ophthalmology"},{"key":"1853_CR8","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.jcrs.2013.06.014","volume":"39","author":"A Behndig","year":"2013","unstructured":"Behndig A, Cochener B, G\u00fcell JL, et al. Endophthalmitis prophylaxis in cataract surgery: overview of current practice patterns in 9 European countries. J Cataract Refract Surg. 2013;39:1421\u201331.","journal-title":"J Cataract Refract Surg"},{"key":"1853_CR9","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jcrs.2007.02.032","volume":"33","author":"Escrs Endophthalmitis Study Group","year":"2007","unstructured":"Escrs Endophthalmitis Study Group. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33:978\u201388.","journal-title":"J Cataract Refract Surg"},{"key":"1853_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10792-012-9537-1","volume":"32","author":"DC Han","year":"2012","unstructured":"Han DC, Chee SP. Survey of practice preference pattern in antibiotic prophylaxis against endophthalmitis after cataract surgery in Singapore. Int Ophthalmol. 2012;32:127\u201334.","journal-title":"Int Ophthalmol"},{"key":"1853_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/j.jcrs.0000000000000757","volume":"48","author":"DF Chang","year":"2022","unstructured":"Chang DF, Rhee DJ. Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2021 ASCRS member survey. J Cataract Refract Surg. 2022;48:3\u20137.","journal-title":"J Cataract Refract Surg"},{"key":"1853_CR12","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2147\/OPTH.S74249","volume":"9","author":"B \u00c7ak\u0131r","year":"2015","unstructured":"\u00c7ak\u0131r B, Celik E, Aksoy N\u00d6, et al. Toxic anterior segment syndrome after uncomplicated cataract surgery possibly associated with intracamaral use of cefuroxime. Clin Ophthalmol. 2015;9:493\u20137.","journal-title":"Clin Ophthalmol"},{"key":"1853_CR13","doi-asserted-by":"publisher","first-page":"101218","DOI":"10.1016\/j.preteyeres.2023.101218","volume":"97","author":"T Das","year":"2023","unstructured":"Das T, Joseph J, Simunovic M, et al. Consensus and controversies in the science of endophthalmitis management: basic research and clinical perspectives. Prog Retin Eye Res. 2023;97:101218.","journal-title":"Prog Retin Eye Res"},{"key":"1853_CR14","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","volume":"375","author":"RE Sherman","year":"2016","unstructured":"Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence\u2014what is it and what can it tell us. N Engl J Med. 2016;375:2293\u20137.","journal-title":"N Engl J Med"},{"key":"1853_CR15","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1056\/NEJMp1614720","volume":"376","author":"M Najafzadeh","year":"2017","unstructured":"Najafzadeh M, Schneeweiss S. From trial to target populations\u2014calibrating real-world data. N Engl J Med. 2017;376:1203\u20135.","journal-title":"N Engl J Med"},{"key":"1853_CR16","first-page":"348","volume":"46","author":"JL Bernal","year":"2017","unstructured":"Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: A tutorial. Int J Epidemiol. 2017;46:348\u201355.","journal-title":"Int J Epidemiol"},{"key":"1853_CR17","first-page":"CD006364","volume":"2","author":"EW Gower","year":"2017","unstructured":"Gower EW, Lindsley K, Tulenko SE, et al. Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery. Cochrane Database Syst Rev. 2017;2:CD006364.","journal-title":"Cochrane Database Syst Rev"},{"key":"1853_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/CLEP.S196293","volume":"11","author":"CY Hsieh","year":"2019","unstructured":"Hsieh CY, Su CC, Shao SC, et al. Taiwan\u2019s national health insurance research database: past and future. Clin Epidemiol. 2019;11:349\u201358.","journal-title":"Clin Epidemiol"},{"key":"1853_CR19","doi-asserted-by":"publisher","first-page":"e112257","DOI":"10.1371\/journal.pone.0112257","volume":"9","author":"CS Wu","year":"2014","unstructured":"Wu CS, Lai MS, Gau SSF, et al. Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan. PLoS ONE. 2014;9:e112257.","journal-title":"PLoS ONE"},{"key":"1853_CR20","unstructured":"National Health Insurance Administration, Ministry of Health and Welfare, Taiwan. Payment code inquiry for diagnosis, procedure, and medication. https:\/\/info.nhi.gov.tw\/INAE5000\/INAE5001S01. Accessed 28 Oct 2024."},{"key":"1853_CR21","first-page":"893","volume":"54","author":"J Ng","year":"2013","unstructured":"Ng J, Morlet N, Clark A. Anterior vitrectomy at the time of cataract surgery: a whole-population study of the incidence and consequences. Invest Ophthalmol Vis Sci. 2013;54:893\u2013893.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1853_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000521288","volume":"91","author":"ME Charlson","year":"2022","unstructured":"Charlson ME, Carrozzino D, Guidi J, et al. Charlson comorbidity index: a critical review of clinimetric properties. Psychother Psychosom. 2022;91:8\u201335.","journal-title":"Psychother Psychosom"},{"key":"1853_CR23","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1055\/s-0038-1634956","volume":"32","author":"W D\u2019hoore","year":"1993","unstructured":"D\u2019hoore W, Sicotte C, Tilquin C. Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med. 1993;32:382\u20137.","journal-title":"Methods Inf Med"},{"key":"1853_CR24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1524-4733.2009.00671.x","volume":"13","author":"S Xu","year":"2010","unstructured":"Xu S, Ross C, Raebel MA, et al. Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals. Value Health. 2010;13:273\u20137.","journal-title":"Value Health"},{"key":"1853_CR25","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1002\/sim.5753","volume":"32","author":"DF Mccaffrey","year":"2013","unstructured":"Mccaffrey DF, Griffin BA, Almirall D, et al. A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Stat Med. 2013;32:3388\u2013414.","journal-title":"Stat Med"},{"key":"1853_CR26","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1080\/03610910902859574","volume":"38","author":"PC Austin","year":"2009","unstructured":"Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput. 2009;38:1228\u201334.","journal-title":"Commun Stat Simul Comput"},{"key":"1853_CR27","unstructured":"Division of Cancer Control and Population Sciences, National Cancer Institute. How joinpoint selects the final model. https:\/\/surveillance.cancer.gov\/help\/joinpoint\/setting-parameters\/method-and-parameters-tab\/model-selection-method. Accessed 04 Dec 2024."},{"key":"1853_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","volume":"27","author":"AK Wagner","year":"2002","unstructured":"Wagner AK, Soumerai SB, Zhang F, et al. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27:299\u2013309.","journal-title":"J Clin Pharm Ther"},{"key":"1853_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12874-017-0317-5","volume":"17","author":"Y Hu","year":"2017","unstructured":"Hu Y, Van Lenthe FJ, Hoffmann R, et al. Assessing the impact of natural policy experiments on socioeconomic inequalities in health: How to apply commonly used quantitative analytical methods? BMC Med Res Methodol. 2017;17:68.","journal-title":"BMC Med Res Methodol"},{"key":"1853_CR30","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","volume":"126","author":"P Schober","year":"2018","unstructured":"Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126:1763\u20138.","journal-title":"Anesth Analg"},{"key":"1853_CR31","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jcrs.2015.01.014","volume":"41","author":"DF Chang","year":"2015","unstructured":"Chang DF, Braga-Mele R, Henderson BA, et al. Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2014 ASCRS member survey. J Cataract Refract Surg. 2015;41:1300\u20135.","journal-title":"J Cataract Refract Surg"},{"key":"1853_CR32","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.4103\/ijo.IJO_961_17","volume":"65","author":"A Haripriya","year":"2017","unstructured":"Haripriya A. Antibiotic prophylaxis in cataract surger: an evidence-based approach. Indian J Ophthalmol. 2017;65:1390\u20135.","journal-title":"Indian J Ophthalmol"},{"key":"1853_CR33","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.jcrs.2007.07.009","volume":"33","author":"DF Chang","year":"2007","unstructured":"Chang DF, Braga-Mele R, Mamalis N, et al. Prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2007 ASCRS member survey. J Cataract Refract Surg. 2007;33:1801\u20135.","journal-title":"J Cataract Refract Surg"},{"key":"1853_CR34","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.2165\/00003495-200969090-00009","volume":"69","author":"GM Keating","year":"2009","unstructured":"Keating GM. Levofloxacin 0.5% ophthalmic solution. Drugs. 2009;69:1267\u201386.","journal-title":"Drugs"},{"key":"1853_CR35","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S1369-5274(99)00008-9","volume":"2","author":"K Drlica","year":"1999","unstructured":"Drlica K. Mechanism of fluoroquinolone action. Curr Opin Microbiol. 1999;2:504\u20138.","journal-title":"Curr Opin Microbiol"},{"key":"1853_CR36","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1167\/iovs.06-0141","volume":"47","author":"SY Kim","year":"2006","unstructured":"Kim SY, Lim JA, Choi JS, et al. Comparison of antibiotic effect & corneal epithelial toxicity between levofloxacin 0.5% (Cravit\u00ae) & moxifloxacin 0.5% (Vigamox\u00ae) in vitro. Invest Ophthalmol Vis Sci. 2006;47:3565\u20133565.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1853_CR37","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3349\/ymj.2014.55.1.197","volume":"55","author":"KE Han","year":"2014","unstructured":"Han KE, Chung WS, Kim TI, et al. Epithelial wound healing after cataract surgery comparing two different topical fluoroquinolones. Yonsei Med J. 2014;55:197\u2013202.","journal-title":"Yonsei Med J"},{"key":"1853_CR38","doi-asserted-by":"publisher","first-page":"772","DOI":"10.12688\/f1000research.133293.1","volume":"12","author":"L Edwar","year":"2023","unstructured":"Edwar L, Bisara BB, Setiabudi R, et al. Safety of intracameral injection of levofloxacin 0.5% eye drops single dose 0.6 ml preservative free on rabbit eye. F1000Res. 2023;12:772.","journal-title":"F1000Res"},{"key":"1853_CR39","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jclinepi.2022.03.022","volume":"148","author":"A Drosdowsky","year":"2022","unstructured":"Drosdowsky A, Gough K. The Charlson comorbidity index: problems with use in epidemiological research. J Clin Epidemiol. 2022;148:174\u20137.","journal-title":"J Clin Epidemiol"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01853-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-024-01853-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01853-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T20:45:52Z","timestamp":1742330752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-024-01853-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1853"],"URL":"https:\/\/doi.org\/10.1007\/s11096-024-01853-4","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"type":"print","value":"2210-7703"},{"type":"electronic","value":"2210-7711"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"18 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}